GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

But, like all medications, there are side effects to using both Ozempic and Mounjaro with several celebrities sharing their ...

A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between ...

A study presented at ACC 2025 found that colchicine use in diabetic patients without CAD significantly reduced 3-year ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

Glucagon-like peptide 1 receptor agonists, which are found in Ozempic-like drugs, can could cause devastating symptoms in ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...